Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Steno Diabetes Center Odense (SDCO) is a specialized hospital and research institution dedicated to the treatment, prevention, and study of diabetes. Located in Odense, Denmark, it operates as a partnership between the Region of Southern Denmark and the Novo Nordisk Foundation. The center provides integrated clinical care for thousands of patients while simultaneously conducting high-impact clinical research in endocrinology and metabolism. Key research areas include personalized medicine, digital health solutions, and the development of new educational models for patient self-management. SDCO collaborates extensively with Odense University Hospital and the University of Southern Denmark to translate scientific findings into clinical practice.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Steno Diabetes Center Odense.